Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair. (Q40170614)
Jump to navigation
Jump to search
scientific article published on June 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair. |
scientific article published on June 2015 |
Statements
Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair (English)
Alayna E Loiselle
Kiminori Yukata
Sirish Kondabolu
Shanshan Shi
Jennifer H Jonason
Regis J O'Keefe
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference